Muna Therapeutics is a privately held biopharmaceutical company focused on discovering and developing therapies that slow or stop neurodegenerative diseases including Alzheimer’s, Frontotemporal Dementia, and Parkinson’s
Muna Therapeutics is a privately held biopharmaceutical company focused on discovering and developing therapies that slow or stop neurodegenerative diseases including Alzheimer’s, Frontotemporal Dementia, and Parkinson’s. The company aims to preserve cognition and enhance resilience to these diseases through innovative science.